Published in J Immunol on June 01, 1989
Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med (1996) 2.67
Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med (1994) 2.44
Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation. J Immunol (1993) 1.65
Complete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient. Int Immunol (1991) 1.50
Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes. J Clin Invest (1992) 1.46
Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors. J Immunol (1993) 1.46
Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies. J Immunol (1992) 1.45
Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus. J Exp Med (1990) 1.38
Genetic analysis of self-associating immunoglobulin G rheumatoid factors from two rheumatoid synovia implicates an antigen-driven response. J Exp Med (1992) 1.32
Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection. J Immunol (1993) 1.27
Evidence for somatic selection of natural autoantibodies. J Exp Med (1992) 1.26
Molecular characteristics of antibodies bearing an anti-DNA-associated idiotype. J Exp Med (1991) 1.19
New roles for rheumatoid factor. J Clin Invest (1991) 1.16
Variable region diversity in human circulating antibodies specific for the capsular polysaccharide of Haemophilus influenzae type b. Preferential usage of two types of VH3 heavy chains. J Clin Invest (1991) 1.15
Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation. J Clin Invest (1997) 1.15
Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes. J Clin Invest (1991) 1.12
Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus. J Immunol (1994) 1.08
Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment. J Exp Med (1993) 1.07
Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody. J Clin Invest (1992) 1.05
Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift. J Clin Invest (1992) 1.03
Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus. J Immunol (2013) 1.00
The role of complement in the acquired immune response. Immunology (2000) 0.98
Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidase. Int Immunol (1993) 0.98
VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection. J Immunol (1997) 0.95
Extensive and selective mutation of a rearranged VH5 gene in human B cell chronic lymphocytic leukemia. J Exp Med (1992) 0.95
Natural polyreactive immunoglobulin A antibodies produced in mouse Peyer's patches. Immunology (1999) 0.93
Sequence analyses of three immunoglobulin G anti-virus antibodies reveal their utilization of autoantibody-related immunoglobulin Vh genes, but not V lambda genes. J Clin Invest (1992) 0.92
Selective expression of a VHIV subfamily of immunoglobulin genes in human CD5+ B lymphocytes from cord blood. J Exp Med (1991) 0.91
VH and V kappa segment structure of anti-insulin IgG autoantibodies in patients with insulin-dependent diabetes mellitus. Evidence for somatic selection. J Immunol (1994) 0.90
Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene-segment use in mu and gamma transcripts. Proc Natl Acad Sci U S A (1993) 0.88
Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis. J Immunol (1998) 0.86
Chimaeric monoclonal antibodies encoded by the human VH26 gene from naïve transgenic mice display a wide range of antigen-binding specificities. Immunology (1996) 0.86
Clonally-related immunoglobulin VH domains and nonrandom use of DH gene segments in rheumatoid arthritis synovium. Mol Med (1998) 0.86
Natural autoantibodies, IgG antibodies to tetanus toxoid and CD5+ B cells in patients with Mediterranean visceral leishmaniasis. The Leishmania Study Group. Clin Exp Immunol (1994) 0.83
Human monoclonal antibodies specific for blood group antigens demonstrate multispecific properties characteristic of natural autoantibodies. Immunology (1992) 0.82
VH usage and somatic hypermutation in peripheral blood B cells of patients with rheumatoid arthritis (RA). Clin Exp Immunol (1998) 0.82
A somatically mutated V kappa IV gene encoding a human rheumatoid factor light chain. Clin Exp Immunol (1992) 0.81
Genetic analysis of the variable region genes encoding a monospecific human natural anti-DNA antibody. Clin Exp Immunol (1993) 0.81
Immunoglobulin heavy chain variable region gene utilization by B cell hybridomas derived from rheumatoid synovial tissue. Clin Exp Immunol (1992) 0.81
Characterization of a human monoclonal autoantibody directed to cardiolipin/beta 2 glycoprotein I produced by chronic lymphocytic leukaemia B cells. Clin Exp Immunol (1993) 0.81
Human hybridomas derived from CD5+ B lymphocytes of patients with chronic lymphocytic leukemia (B-CLL) produce multi-specific natural IgM (kappa) antibodies. Clin Exp Immunol (1991) 0.80
Molecular characteristics of anti-self antibody fragments against neutrophil cytoplasmic antigens from human V gene phage display libraries. Clin Exp Immunol (1995) 0.78
Generation of human monoclonal antibodies by transformation of lymphoblastoid B cells with ras oncogene. J Immunol Methods (1993) 0.77
IVIG-bound IgG and IgM cloned by phage display from a healthy individual reveal the same restricted germ-line gene origin as in autoimmune thrombocytopenia. Clin Exp Immunol (2000) 0.76
Molecular determinants of polyreactive antibody binding: HCDR3 and cyclic peptides. Clin Exp Immunol (2000) 0.76
Autoantibodies and antibacterial antibodies: from both sides now. Ann Rheum Dis (1990) 0.76
Persistence of a rheumatoid factor (RF)-producing B cell clone with a somatically mutated Ig kappa chain in a patient with rheumatoid arthritis. Clin Exp Immunol (1994) 0.75
Plasmodium riboprotein PfP0 induces a deviant humoral immune response in Balb/c mice. J Biomed Biotechnol (2012) 0.75
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1989) 0.75
The concept of access: definition and relationship to consumer satisfaction. Med Care (1981) 10.22
Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med (1979) 5.58
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol (2005) 5.27
Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity. J Exp Med (1973) 4.93
Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med (1994) 4.52
Antigenic specificities related to the cold agglutinin activity of gamma M globulins. Science (1968) 4.32
Effect of virus infections on the function of the immune system. Annu Rev Microbiol (1970) 4.30
Interaction of cell-type-specific nuclear proteins with immunoglobulin VH promoter region sequences. Nature (1986) 4.21
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (1985) 3.62
Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med (1979) 3.62
Automated amino acid sequence of small peptides utilizing Polybrene. Anal Biochem (1978) 3.48
Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests. Clin Exp Immunol (1977) 3.27
Neisseria gonorrhoeae and neisseria meningitidis: extracellular enzyme cleaves human immunoglobulin A. Science (1975) 3.27
Increasing Medicare enrollment in HMOs: the need for capitation rates adjusted for health status. Inquiry (1983) 3.21
HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15
Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet (1999) 3.15
Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature (1998) 3.11
CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today (1989) 2.96
Thymus dependence of viral antigens. Nature (1975) 2.95
Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus. J Immunol (1968) 2.90
Continued expression of a poly(A)+ transcript of herpes simplex virus type 1 in trigeminal ganglia of latently infected mice. J Virol (1987) 2.78
Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science (1987) 2.75
Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy. Science (1974) 2.71
The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today (1994) 2.71
Infectious virus-antibody complex in the blood of chronically infected mice. J Exp Med (1966) 2.68
Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Annu Rev Immunol (1989) 2.63
Functional health measure for adjusting health maintenance organization capitation rates. Health Care Financ Rev (1986) 2.63
Initial characterization of monoclonal antibodies against human monocytes. Proc Natl Acad Sci U S A (1980) 2.61
Similarities in the light chains of anti-gamma-globulins showing cross-idiotypic specificities. J Exp Med (1974) 2.60
Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A (1992) 2.48
Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat Med (1997) 2.47
Inhibition or enhancement of immunological injury of virus-infected cells. Proc Natl Acad Sci U S A (1971) 2.45
Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med (1994) 2.44
Prevention of cell-to-cell spread of herpes simplex virus by leukocytes. J Exp Med (1973) 2.42
Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J Exp Med (1998) 2.39
Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science (1985) 2.34
In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus. Proc Natl Acad Sci U S A (1972) 2.29
Comparison of direct and indirect solid-phase microradioimmunoassays for the detection of viral antigens and antiviral antibody. Appl Microbiol (1973) 2.23
Immune mechanisms by which the spread of viral infections is stopped. Cell Immunol (1974) 2.23
Aggregation of gamma-G3 proteins: relevance to the hyperviscosity syndrome. J Clin Invest (1970) 2.19
Organization of the immune response genes. Science (1979) 2.18
HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology (1991) 2.16
The smaller human VH gene families display remarkably little polymorphism. EMBO J (1989) 2.15
Subunit structure and N-terminal amino acid sequence of the three chains of cholera enterotoxin. Immunochemistry (1976) 2.14
Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol (1994) 2.13
Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus. J Exp Med (1980) 2.07
NHLBI plans for the promise of cell-based therapies. Cytotherapy (2005) 2.04
Herpes simplex virus DNA and mRNA sequences in acutely and chronically infected trigeminal ganglia of mice. Virology (1978) 1.99
Hypervariable regions, idiotypy, and the antibody-combining site. Adv Immunol (1975) 1.99
The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation. Immunity (2001) 1.98
IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines. Cancer Res (1993) 1.96
Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization. Science (1975) 1.95
Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virus. Nature (1976) 1.95
Herpes simplex virus DNA sequences in the CNS of latently infected mice. Nature (1980) 1.95
Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol (1986) 1.95
Viruses disrupt functions of human lymphocytes. Effects of measles virus and influenza virus on lymphocyte-mediated killing and antibody production. J Exp Med (1984) 1.92
CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. J Immunol (1998) 1.92
Differential susceptibility of human IgA immunoglobulins to streptococcal IgA protease. J Clin Invest (1974) 1.91
Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care (2000) 1.91
Including health status in Medicare's Adjusted Average Per Capita Cost capitation formula. Med Care (1986) 1.88
The amino acid sequence of ragweed pollen allergen Ra5. Biochemistry (1975) 1.85
Structure of antibodies with shared idiotypy: the complete sequence of the heavy chain variable regions of two immunoglobulin M anti-gamma globulins. Proc Natl Acad Sci U S A (1974) 1.84
Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin. Proc Natl Acad Sci U S A (1966) 1.84
Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination. J Virol (1988) 1.81
Rapid micro-radioimmunoassay for the measurement of antiviral antibody. J Immunol (1972) 1.79
Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science (1983) 1.78
Latent infection of the peripheral ANS with herpes simplex virus. Nature (1975) 1.76
Alpha and beta chains of SB and DR antigens are structurally distinct. J Exp Med (1982) 1.76
The protein products of the murine 17th chromosome: genetics and structure. Adv Immunol (1978) 1.76
Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.74
Drugs ten years later: epirubicin. Ann Oncol (1993) 1.74
Human monoclonal autoantibodies that react with multiple endocrine organs. N Engl J Med (1983) 1.73
Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon. J Exp Med (1977) 1.73
Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum (1982) 1.73
Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity. J Exp Med (1981) 1.72
Immune response gene control of determinant selection. III. Polypeptide fragments of insulin are differentially recognized by T but not by B cells in insulin immune guinea pigs. J Immunol (1981) 1.71
Elevated gamma-globulin and increased antibody production in mice infected with lactic dehydrogenase virus. J Exp Med (1966) 1.71
IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1996) 1.71
Amino acid sequence of ragweed allergen Ra3. Biochemistry (1980) 1.71
Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation. J Gen Virol (1979) 1.71
Structure-function relationships among anti-gamma globulin antibodies. Ann N Y Acad Sci (1971) 1.71
Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation. J Exp Med (1979) 1.70
Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol (1984) 1.69
Virus-induced diabetes mellitus. I. Hyperglycemia and hypoinsulinemia in mice infected with encephalomyocarditis virus. J Exp Med (1973) 1.68
Human immunoglobulin heavy-chain variable region genes: organization, polymorphism, and expression. Adv Immunol (1991) 1.68
Homology between murine and human cellular DNA sequences and the terminal repetition of the S component of herpes simplex virus type 1 DNA. Cell (1982) 1.67
Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation. J Immunol (1993) 1.65
Light chain sequences of human IgM cold agglutinins (variable-region subgroups amino-acid sequence-kappa light chain-N-terminal). Proc Natl Acad Sci U S A (1972) 1.64
Multiple organ-reactive monoclonal autoantibodies. Nature (1983) 1.64
Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum (1998) 1.63
Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci U S A (1970) 1.63
Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. J Exp Med (1988) 1.62